Get the Stockscreener App
5.95
0.85%
0.05
After Hours:
5.97
0.02
+0.34%
Champions Oncology Inc Stock (CSBR) Forecast
The Champions Oncology Inc (CSBR) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $7.5794, representing a +27.39% increase from the current price of $5.95. The highest analyst price target is $8.2967, and the lowest is $6.8622.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CSBR Price Target
Average 8.4704
(+42.36% Upside)
Is Champions Oncology Inc (CSBR) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 33.96 | Neutral |
| STOCH(9,6) | 1.0794 | Buy |
| STOCHRSI(14) | 4.0913 | Buy |
| MACD(12,26) | -0.199 | Sell |
| ADX(14) | 22.98 | Neutral |
| William %R | -97.24 | Buy |
| CCI(14) | -129.91 | Sell |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
6.6042
Sell
|
6.4548
Sell
|
| MA20 |
6.8757
Sell
|
6.6754
Sell
|
| MA50 |
6.7478
Sell
|
6.7652
Sell
|
| MA100 |
6.6952
Sell
|
6.7927
Sell
|
| MA200 |
6.8094
Sell
|
6.8997
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, CSBR could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 12 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on CSBR, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 33.96 indicates that CSBR is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 1.0794 indicates that CSBR is oversold. This indicates that CSBR price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 4.0913 indicates that CSBR is oversold. This suggests that CSBR price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 22.98 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -129.91 indicates that CSBR is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term CSBR price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Champions Oncology Inc financial reports and earnings history, Champions Oncology Inc (CSBR) stock could reach $3.0439 by 2030, $2.8012 by 2040 and $5.999 by 2050. See the projected annual prices until 2050 of the Champions Oncology Inc stock below:
- Champions Oncology Inc (CSBR) is expected to reach an average price of $0.9785 in 2035, with a high prediction of $1.2846 and a low estimate of $0.5856. This indicates an $-83.55% rise from the last recorded price of $5.95.
- Champions Oncology Inc (CSBR) stock is projected to chart a bullish course in 2040, with an average price target of $2.4218, representing an $-59.30% surge from its current level. The forecast ranges from a conservative $2.4218 to a sky-high $2.8012.
- Our analysts predict Champions Oncology Inc (CSBR) to jump -49.36% by 2045, soaring from $2.8171 to an average price of $3.0132, potentially reaching $2.6332. While $2.8171 is the low estimate, the potential upside is significant.
- Champions Oncology Inc (CSBR) stock is expected to climb by 2050, reaching an average of $5.5667, a $-6.44% jump from its current level. However, a wide range of estimates exists, with high and low targets of $5.999 and $6.279, respectively, highlighting the market's uncertainty.
Champions Oncology Inc Stock (CSBR) Year by Year Forecast
Champions Oncology Inc Stock (CSBR) Price Forecast for 2026
The predicted value for Champions Oncology Inc (CSBR) in 2026 is set at an average of $8.3021. Estimates vary from a peak of $11.55 to a trough of $5.0573, indicating an +39.53% surge from the present price of $5.95.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2026 | $8.0576 | $6.8622 | $8.2967 | +35.42% |
| April, 2026 | $8.1951 | $7.2551 | $9.4386 | +37.73% |
| May, 2026 | $9.337 | $7.6615 | $11.55 | +56.92% |
| June, 2026 | $8.2089 | $6.9489 | $10.02 | +37.97% |
| July, 2026 | $6.4664 | $5.7209 | $8.7594 | +8.68% |
| August, 2026 | $6.5183 | $5.9883 | $7.2673 | +9.55% |
| September, 2026 | $6.6157 | $5.3938 | $8.2048 | +11.19% |
| October, 2026 | $7.5877 | $6.0412 | $7.8548 | +27.52% |
| November, 2026 | $6.6996 | $6.2396 | $7.8332 | +12.60% |
| December, 2026 | $7.2471 | $6.6006 | $8.0151 | +21.80% |
Champions Oncology Inc Stock (CSBR) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Champions Oncology Inc (CSBR) is $5.7528, with a high forecast of $7.45 and a low forecast of $4.0555. This indicates an -3.32% decrease from the last price of $5.95.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $7.029 | $6.918 | $7.3725 | +18.13% |
| February, 2027 | $6.4509 | $6.2709 | $7.45 | +8.42% |
| March, 2027 | $5.1984 | $4.9029 | $6.3764 | -12.63% |
| April, 2027 | $5.1603 | $4.864 | $6.2532 | -13.27% |
| May, 2027 | $4.9711 | $4.7413 | $5.3158 | -16.45% |
| June, 2027 | $5.3197 | $4.2578 | $5.7797 | -10.59% |
| July, 2027 | $5.3316 | $4.2507 | $6.1207 | -10.39% |
| August, 2027 | $5.1339 | $4.6637 | $5.8626 | -13.72% |
| September, 2027 | $4.521 | $4.0555 | $5.1691 | -24.02% |
| October, 2027 | $4.843 | $4.483 | $5.173 | -18.61% |
| November, 2027 | $5.1949 | $4.6502 | $5.5299 | -12.69% |
| December, 2027 | $6.7923 | $4.8025 | $7.2023 | +14.16% |
Champions Oncology Inc Stock (CSBR) Price Forecast for 2028
In 2028, Champions Oncology Inc (CSBR) is projected to reach an average price of $4.0354, with a high projection of $6.8778 and a low estimate of $1.193. This indicates an -32.18% fall from the last price of $5.95.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $4.9643 | $4.8443 | $6.8778 | -16.57% |
| February, 2028 | $4.8662 | $4.5098 | $6.5107 | -18.21% |
| March, 2028 | $4.3336 | $4.2882 | $5.2726 | -27.17% |
| April, 2028 | $4.2106 | $3.5147 | $4.6544 | -29.23% |
| May, 2028 | $1.923 | $1.193 | $4.6366 | -67.68% |
| June, 2028 | $1.545 | $1.545 | $2.1385 | -74.03% |
| July, 2028 | $1.6169 | $1.5204 | $1.8214 | -72.83% |
| August, 2028 | $2.0042 | $1.5924 | $2.2934 | -66.32% |
| September, 2028 | $2.0563 | $1.4753 | $2.1263 | -65.44% |
| October, 2028 | $2.7282 | $1.9082 | $3.0873 | -54.15% |
| November, 2028 | $2.8257 | $1.7337 | $2.9646 | -52.51% |
| December, 2028 | $3.9876 | $2.6911 | $4.4066 | -32.98% |
Champions Oncology Inc Stock (CSBR) Price Forecast for 2029
The 2029 price forecast for Champions Oncology Inc Stock (CSBR) is $2.9103 on average, with a high prediction of $4.9441 and a low estimate of $0.8766. This represents an -51.09% decrease from the previous price of $5.95.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $4.135 | $3.7231 | $4.9441 | -30.50% |
| February, 2029 | $4.257 | $3.746 | $4.576 | -28.45% |
| March, 2029 | $2.9289 | $2.8389 | $4.4479 | -50.77% |
| April, 2029 | $3.8509 | $2.7844 | $4.3304 | -35.28% |
| May, 2029 | $3.3083 | $2.8628 | $4.7256 | -44.40% |
| June, 2029 | $3.0502 | $2.7602 | $3.4838 | -48.74% |
| July, 2029 | $3.3921 | $2.2768 | $3.6372 | -42.99% |
| August, 2029 | $3.6096 | $3.1777 | $4.9189 | -39.33% |
| September, 2029 | $3.5015 | $3.4561 | $4.0706 | -41.15% |
| October, 2029 | $3.249 | $2.7346 | $4.088 | -45.40% |
| November, 2029 | $2.9309 | $2.6304 | $3.1654 | -50.74% |
| December, 2029 | $1.14 | $0.8766 | $3.0149 | -80.84% |
Champions Oncology Inc Stock (CSBR) Price Forecast for 2030
Champions Oncology Inc Stock (CSBR) is expected to reach an average price of $1.56 in 2030, with a high forecast of $3.0439 and a low forecast of $0.0762. This signifies an -73.78% decrease from the last price of $5.95.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.2933 | $0.591 | $3.0439 | -78.26% |
| February, 2030 | $0.7587 | $0.1578 | $1.5758 | -87.25% |
| March, 2030 | $1.2874 | $0.1697 | $1.8707 | -78.36% |
| April, 2030 | $1.8635 | $1.6644 | $1.1964 | -68.68% |
| May, 2030 | $1.5786 | $1.2415 | $1.5786 | -73.47% |
| June, 2030 | $1.4547 | $1.5247 | $1.3276 | -75.55% |
| July, 2030 | $1.6299 | $1.8928 | $1.6618 | -72.61% |
| August, 2030 | $0.344 | $0.196 | $1.734 | -94.22% |
| September, 2030 | $1.0179 | $0.436 | $1.6479 | -82.89% |
| October, 2030 | $0.1628 | $0.1472 | $1.6739 | -97.26% |
| November, 2030 | $1.2133 | $0.0762 | $0.4737 | -79.61% |
| December, 2030 | $0.2395 | $0.3095 | $0.9024 | -95.98% |
1.24%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):